The DOI matches its Crossref record; 308 of the 308 references it cites were found in a registry or an index.
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Open accessAbstract
The macrophage is a key cell in the pro- and anti-inflammatory response including that of the inflammatory microenvironment of malignant tumors. Much current drug development in chronic inflammatory diseases and cancer therefore focuses on the macrophage as a target for immunotherapy. However, this strategy is complicated by the pleiotropic phenotype of the macrophage that is highly responsive to its microenvironment. The plasticity leads to numerous types of macrophages with rather different and, to some extent, opposing functionalities, as evident by the existence of macrophages with either stimulating or down-regulating effect on inflammation and tumor growth. The phenotypes are characterized by different surface markers and the present review describes recent progress in drug-targeting of the surface marker CD163 expressed in a subpopulation of macrophages. CD163 is an abundant endocytic receptor for multiple ligands, quantitatively important being the haptoglobin-hemoglobin complex. The microenvironment of inflammation and tumorigenesis is particular rich in CD163+ macrophages. The use of antibodies for directing anti-inflammatory (e.g., glucocorticoids) or tumoricidal (e.g., doxorubicin) drugs to CD163+ macrophages in animal models of inflammation and cancer has demonstrated a high efficacy of the conjugate drugs. This macrophage-targeting approach has a low toxicity profile that may highly improve the therapeutic window of many current drugs and drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Macrophage plasticity, polarization, and function in health and disease
Shapouri‐Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26429 · Cited by 4,930
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
Arango Duque, G., & Descoteaux, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00491 · Cited by 2,708
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
Stein, M., Keshav, S., Harris, N., & Gordon, S. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.287 · Cited by 1,960
Single-cell RNA sequencing to explore immune cell heterogeneity
Papalexi, E., & Satija, R. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.76 · Cited by 1,806
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Self-citationLandscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Zhang, Q., He, Y., Luo, N., Patel, S. J., Han, Y., Gao, R., Modak, M., Carotta, S., Haslinger, C., Kind, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.003 · Cited by 1,624
Zilionis, R., Engblom, C., Pfirschke, C., Savova, V., Zemmour, D., Saatcioglu, H. D., Krishnan, I., Maroni, G., Meyerovitz, C. V., Kerwin, C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.009 · Cited by 1,475
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
CELLULAR RESISTANCE TO INFECTION
Mackaness, G. B. (1962) · The Journal of Experimental Medicine · doi:10.1084/jem.116.3.381 · Cited by 1,361
Singh, N., Baby, D., Rajguru, J., Patil, P., Thakkannavar, S., & Pujari, V. (2019) · Annals of African Medicine · doi:10.4103/aam.aam_56_18 · Cited by 1,333
Gosselin, D., Link, V. M., Romanoski, C. E., Fonseca, G. J., Eichenfield, D. Z., Spann, N. J., Stender, J. D., Chun, H. B., Garner, H., Geissmann, F., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.023 · Cited by 1,307
Immunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
Targeting tumor-associated macrophages in cancer
Pathria, P., Louis, T. L., & Varner, J. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.02.003 · Cited by 933
Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD
Na, Y. R., Stakenborg, M., Seok, S. H., & Matteoli, G. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0172-4 · Cited by 900
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Ino, Y., Yamazaki-Itoh, R., Shimada, K., Iwasaki, M., Kosuge, T., Kanai, Y., & Hiraoka, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.32 · Cited by 849
Wei, C., Yang, C., Wang, S., Shi, D., Zhang, C., Lin, X., Liu, Q., Dou, R., & Xiong, B. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0976-4 · Cited by 833
New insights into the multidimensional concept of macrophage ontogeny, activation and function
Ginhoux, F., Schultze, J. L., Murray, P. J., Ochando, J., & Biswas, S. K. (2016) · Nature Immunology · doi:10.1038/ni.3324 · Cited by 833
The immune cell landscape in kidneys of patients with lupus nephritis
the Accelerating Medicines Partnership in SLE network, Arazi, A., Rao, D. A., Berthier, C. C., Davidson, A., Liu, Y., Hoover, P. J., Chicoine, A., Eisenhaure, T. M., Jonsson, A. H., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0398-x · Cited by 827
Macrophages in inflammation, repair and regeneration
Oishi, Y., & Manabe, I. (2018) · International Immunology · doi:10.1093/intimm/dxy054 · Cited by 734
Atherosclerosis and inflammation: overview and updates
Geovanini, G. R., & Libby, P. (2018) · Clinical Science · doi:10.1042/cs20180306 · Cited by 703
Medrek, C., Pontén, F., Jirström, K., & Leandersson, K. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-306 · Cited by 647
CD163 and Inflammation: Biological, Diagnostic, and Therapeutic Aspects
Etzerodt, A., & Moestrup, S. K. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4834 · Cited by 604
Self-citationLiposomal Drug Delivery Systems and Anticancer Drugs
Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., & Elkordy, A. (2018) · Molecules · doi:10.3390/molecules23040907 · Cited by 603
Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages
Barros, M. H. M., Hauck, F., Dreyer, J. H., Kempkes, B., & Niedobitek, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080908 · Cited by 594
Obstacles and opportunities for understanding macrophage polarization
Murray, P. J., & Wynn, T. A. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710409 · Cited by 563
Significance of M2-Polarized Tumor-Associated Macrophage in Pancreatic Cancer
Kurahara, H., Shinchi, H., Mataki, Y., Maemura, K., Noma, H., Kubo, F., Sakoda, M., Ueno, S., Natsugoe, S., & Takao, S. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2009.05.026 · Cited by 552
Clinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2014) · Cancer Science · doi:10.1111/cas.12314 · Cited by 551
Martinez, F. O., Helming, L., Milde, R., Varin, A., Melgert, B. N., Draijer, C., Thomas, B., Fabbri, M., Crawshaw, A., Ho, L. P., et al. (2013) · Blood · doi:10.1182/blood-2012-06-436212 · Cited by 507
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479
Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada, A., Gray, P. W., Rinderknecht, E., & Schreiber, R. D. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.1.55 · Cited by 465
Antibody-Drug Conjugate-Based Therapeutics: State of the Science
Birrer, M. J., Moore, K. N., Betella, I., & Bates, R. C. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz035 · Cited by 439
Ehrchen, J., Steinmüller, L., Barczyk, K., Tenbrock, K., Nacken, W., Eisenacher, M., Nordhues, U., Sorg, C., Sunderkötter, C., & Roth, J. (2007) · Blood · doi:10.1182/blood-2006-02-001115 · Cited by 407
The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria
Fabriek, B. O., van Bruggen, R., Deng, D. M., Ligtenberg, A. J. M., Nazmi, K., Schornagel, K., Vloet, R. P. M., Dijkstra, C. D., & van den Berg, T. K. (2009) · Blood · doi:10.1182/blood-2008-07-167064 · Cited by 389
Welte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237137100 · Cited by 381
Burkard, C., Lillico, S. G., Reid, E., Jackson, B., Mileham, A. J., Ait-Ali, T., Whitelaw, C. B. A., & Archibald, A. L. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006206 · Cited by 378
Monocyte and Macrophage Heterogeneity in the Heart
Nahrendorf, M., & Swirski, F. K. (2013) · Circulation Research · doi:10.1161/circresaha.113.300890 · Cited by 359
Shi, Y., Ping, Y.-F., Zhou, W., He, Z.-C., Chen, C., Bian, B.-S.-J., Zhang, L., Chen, L., Lan, X., Zhang, X.-C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15080 · Cited by 344
Møller, H. J. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.626868 · Cited by 343
Burdo, T. H., Lentz, M. R., Autissier, P., Krishnan, A., Halpern, E., Letendre, S., Rosenberg, E. S., Ellis, R. J., & Williams, K. C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir214 · Cited by 336
Gast, C. E., Silk, A. D., Zarour, L., Riegler, L., Burkhart, J. G., Gustafson, K. T., Parappilly, M. S., Roh-Johnson, M., Goodman, J. R., Olson, B., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat7828 · Cited by 326
Guo, L., Akahori, H., Harari, E., Smith, S. L., Polavarapu, R., Karmali, V., Otsuka, F., Gannon, R. L., Braumann, R. E., Dickinson, M. H., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93025 · Cited by 322
Doyle, A. G., Herbein, G., Montaner, L. J., Minty, A. J., Caput, D., Ferrara, P., & Gordon, S. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240630 · Cited by 306
Tissue‐resident macrophages in omentum promote metastatic spread of ovarian cancer
Etzerodt, A., Moulin, M., Doktor, T. K., Delfini, M., Mossadegh-Keller, N., Bajenoff, M., Sieweke, M. H., Moestrup, S. K., Auphan-Anezin, N., & Lawrence, T. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191869 · Cited by 305
Self-citationChu, F., Shi, M., Zheng, C., Shen, D., Zhu, J., Zheng, X., & Cui, L. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.02.015 · Cited by 303
Jensen, T. O., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9919 · Cited by 299
Belfiore, L., Saunders, D. N., Ranson, M., Thurecht, K. J., Storm, G., & Vine, K. L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.040 · Cited by 294
Reinartz, S., Schumann, T., Finkernagel, F., Wortmann, A., Jansen, J. M., Meissner, W., Krause, M., Schwörer, A., Wagner, U., Müller‐Brüsselbach, S., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28335 · Cited by 271
Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
Komohara, Y., Hasita, H., Ohnishi, K., Fujiwara, Y., Suzu, S., Eto, M., & Takeya, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01945.x · Cited by 264
Jackute, J., Zemaitis, M., Pranys, D., Sitkauskiene, B., Miliauskas, S., Vaitkiene, S., & Sakalauskas, R. (2018) · BMC Immunology · doi:10.1186/s12865-018-0241-4 · Cited by 261
Soluble Macrophage Biomarkers Indicate Inflammatory Phenotypes in Patients With Knee Osteoarthritis
Daghestani, H. N., Pieper, C. F., & Kraus, V. B. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39006 · Cited by 258
He, W., Kapate, N., Shields, C. W., & Mitragotri, S. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.001 · Cited by 236
Tiainen, S., Tumelius, R., Rilla, K., Hämäläinen, K., Tammi, M., Tammi, R., Kosma, V., Oikari, S., & Auvinen, P. (2015) · Histopathology · doi:10.1111/his.12607 · Cited by 234
Lisi, L., Ciotti, G. M. P., Braun, D., Kalinin, S., Currò, D., Dello Russo, C., Coli, A., Mangiola, A., Anile, C., Feinstein, D. L., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.076 · Cited by 231
Etzerodt, A., Tsalkitzi, K., Maniecki, M., Damsky, W., Delfini, M., Baudoin, E., Moulin, M., Bosenberg, M., Graversen, J. H., Auphan-Anezin, N., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20182124 · Cited by 229
Self-citationLan, C., Huang, X., Lin, S., Huang, H., Cai, Q., Wan, T., Lu, J., & Liu, J. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500312 · Cited by 227
Shabo, I., Stål, O., Olsson, H., Doré, S., & Svanvik, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23527 · Cited by 225
Physiological roles of macrophages
Gordon, S., & Martinez-Pomares, L. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1945-7 · Cited by 221
Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival
Bronkhorst, I. H. G., Ly, L. V., Jordanova, E. S., Vrolijk, J., Versluis, M., Luyten, G. P. M., & Jager, M. J. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5979 · Cited by 219
Wang, Q., Ni, H., Lan, L., Wei, X., Xiang, R., & Wang, Y. (2010) · Cell Research · doi:10.1038/cr.2010.52 · Cited by 219
Rosso, C., Kazankov, K., Younes, R., Esmaili, S., Marietti, M., Sacco, M., Carli, F., Gaggini, M., Salomone, F., Møller, H. J., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.031 · Cited by 217
Immune landscapes associated with different glioblastoma molecular subtypes
Martinez-Lage, M., Lynch, T. M., Bi, Y., Cocito, C., Way, G. P., Pal, S., Haller, J., Yan, R. E., Ziober, A., Nguyen, A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0803-6 · Cited by 211
Trombetta, A. C., Soldano, S., Contini, P., Tomatis, V., Ruaro, B., Paolino, S., Brizzolara, R., Montagna, P., Sulli, A., Pizzorni, C., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0891-z · Cited by 210
Tan, K. L., Scott, D. W., Hong, F., Kahl, B. S., Fisher, R. I., Bartlett, N. L., Advani, R. H., Buckstein, R., Rimsza, L. M., Connors, J. M., et al. (2012) · Blood · doi:10.1182/blood-2012-04-421057 · Cited by 208
Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
Jung, K. Y., Cho, S. W., Kim, Y. A., Kim, D., Oh, B.-C., Park, D. J., & Park, Y. J. (2015) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2015.06.01 · Cited by 206
Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
Prosniak, M., Harshyne, L. A., Andrews, D. W., Kenyon, L. C., Bedelbaeva, K., Apanasovich, T. V., Heber-Katz, E., Curtis, M. T., Cotzia, P., & Hooper, D. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1940 · Cited by 203
Schaer, D. J., Schleiffenbaum, B., Kurrer, M., Imhof, A., Bächli, E., Fehr, J., Moller, H. J., Moestrup, S. K., & Schaffner, A. (2005) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00318.x · Cited by 203
Self-citationDolganiuc, A., Norkina, O., Kodys, K., Catalano, D., Bakis, G., Marshall, C., Mandrekar, P., & Szabo, G. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.003 · Cited by 202
Tumor-Associated Macrophages as Target for Antitumor Therapy
Sawa-Wejksza, K., & Kandefer-Szerszeń, M. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0480-8 · Cited by 201
Hu, Y., He, M.-Y., Zhu, L.-F., Yang, C.-C., Zhou, M.-L., Wang, Q., Zhang, W., Zheng, Y.-Y., Wang, D.-M., Xu, Z.-Q., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0281-z · Cited by 197
Fujii, N., Shomori, K., Shiomi, T., Nakabayashi, M., Takeda, C., Ryoke, K., & Ito, H. (2012) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2012.01127.x · Cited by 191
Inflammatory response of macrophages in infection
Zhang, L., & Wang, C.-C. (2014) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(14)60024-2 · Cited by 189
Zimmerman, K. A., Bentley, M. R., Lever, J. M., Li, Z., Crossman, D. K., Song, C. J., Liu, S., Crowley, M. R., George, J. F., Mrug, M., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018090931 · Cited by 181
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
Nielsen, M. C., Hvidbjerg Gantzel, R., Clària, J., Trebicka, J., Møller, H. J., & Grønbæk, H. (2020) · Cells · doi:10.3390/cells9051175 · Cited by 181
Hu, H., Hang, J.-J., Han, T., Zhuo, M., Jiao, F., & Wang, L.-W. (2016) · Tumor Biology · doi:10.1007/s13277-015-4741-z · Cited by 177
Troiano, G., Caponio, V. C. A., Adipietro, I., Tepedino, M., Santoro, R., Laino, L., Lo Russo, L., Cirillo, N., & Lo Muzio, L. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.04.019 · Cited by 177
Pan, Y., Lu, F., Fei, Q., Yu, X., Xiong, P., Yu, X., Dang, Y., Hou, Z., Lin, W., Lin, X., et al. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0822-6 · Cited by 176
Role of tumor‐associated macrophages in human malignancies: friend or foe?
Takeya, M., & Komohara, Y. (2016) · Pathology International · doi:10.1111/pin.12440 · Cited by 174
He, K.-F., Zhang, L., Huang, C.-F., Ma, S.-R., Wang, Y.-F., Wang, W.-M., Zhao, Z.-L., Liu, B., Zhao, Y.-F., Zhang, W.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/838632 · Cited by 172
Kazankov, K., Barrera, F., Mφller, H. J., Bibby, B. M., Vilstrup, H., George, J., & Grφnbæk, H. (2014) · Hepatology · doi:10.1002/hep.27129 · Cited by 172
Pichler, R., Fritz, J., Zavadil, C., Schäfer, G., Culig, Z., & Brunner, A. (2016) · Oncotarget · doi:10.18632/oncotarget.9537 · Cited by 172
Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer
Jeong, H., Hwang, I., Kang, S. H., Shin, H. C., & Kwon, S. Y. (2019) · Journal of Breast Cancer · doi:10.4048/jbc.2019.22.e5 · Cited by 169
STAT3 in cancer: A double edged sword
Avalle, L., Camporeale, A., Camperi, A., & Poli, V. (2017) · Cytokine · doi:10.1016/j.cyto.2017.03.018 · Cited by 168
Andersen, C. B. F., Stødkilde, K., Sæderup, K. L., Kuhlee, A., Raunser, S., Graversen, J. H., & Moestrup, S. K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6793 · Cited by 168
Self-citationPolfliet, M. M. J., Fabriek, B. O., Daniëls, W. P., Dijkstra, C. D., & van den Berg, T. K. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.015 · Cited by 165
Soluble CD163 from activated macrophages predicts mortality in acute liver failure
Møller, H. J., Grønbæk, H., Schiødt, F. V., Holland-Fischer, P., Schilsky, M., Munoz, S., Hassanein, T., & Lee, W. M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.05.014 · Cited by 163
Hu, J. M., Liu, K., Liu, J. H., Jiang, X. L., Wang, X. L., Chen, Y. Z., Li, S. G., Zou, H., Pang, L. J., Liu, C. X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15630 · Cited by 162
Glezeva, N., Voon, V., Watson, C. J., Horgan, S. J., McDonald, K., Ledwidge, M. T., & Baugh, J. A. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.11.004 · Cited by 160
M2 tumor‑associated macrophages promote tumor progression in non‑small‑cell lung cancer
Sumitomo, R., Hirai, T., Fujita, M., Murakami, H., Otake, Y., & Huang, C. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8068 · Cited by 160
Ambarus, C. A., Noordenbos, T., de Hair, M. J., Tak, P. P., & Baeten, D. L. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3796 · Cited by 158
Kubota, K., Moriyama, M., Furukawa, S., Rafiul, H. A. S. M., Maruse, Y., Jinno, T., Tanaka, A., Ohta, M., Ishiguro, N., Yamauchi, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01661-z · Cited by 158
Phenotypic modulation of macrophages in response to plaque lipids
Adamson, S., & Leitinger, N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834a97e4 · Cited by 154
Baeten, D., Kruithof, E., Rycke, L. D., Boots, A. M., Mielants, H., VEYS, E. M., & Keyser, F. D. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1501 · Cited by 154
Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?
Reynolds, G., & Haniffa, M. A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00330 · Cited by 153
CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis
Olmes, G., Büttner-Herold, M. J., Ferrazzi, F., Distel, L. V., Amann, K., & Daniel, C. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0989-y · Cited by 152
Graversen, J. H., Svendsen, P., Dagnæs‐Hansen, F., Dal, J., Anton, G., Etzerodt, A., Petersen, M. D., Christensen, P. A., Møller, H. J., & Moestrup, S. K. (2012) · Molecular Therapy · doi:10.1038/mt.2012.103 · Cited by 150
Self-citationYang, C., Chen, W., Wang, S., Shi, D., Zhang, C., Lin, X., Dou, R., & Xiong, B. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.29836 · Cited by 149
M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
Cao, L., Che, X., Qiu, X.-S., Li, Z., Yang, B., Wang, S., Hou, K., Fan, Y., Qu, X., & Liu, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s199832 · Cited by 149
Shabo, I., Olsson, H., Sun, X., & Svanvik, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24506 · Cited by 148
EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor
Hamann, J., Koning, N., Pouwels, W., Ulfman, L. H., van Eijk, M., Stacey, M. A., Lin, H., Gordon, S., & Kwakkenbos, M. J. (2007) · European Journal of Immunology · doi:10.1002/eji.200737553 · Cited by 148
Sugimura, K., Miyata, H., Tanaka, K., Takahashi, T., Kurokawa, Y., Yamasaki, M., Nakajima, K., Takiguchi, S., Mori, M., & Doki, Y. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23881 · Cited by 147
The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis
Aristoteli, L. P., Møller, H. J., Bailey, B., Moestrup, S. K., & Kritharides, L. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.004 · Cited by 147
Self-citationPredominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity
Vidyarthi, A., Agnihotri, T., Khan, N., Singh, S., Tewari, M. K., Radotra, B., Chatterjee, D., & Agrewala, J. N. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02423-8 · Cited by 147
Tavazzi, E., Morrison, D., Sullivan, P. D., Morgello, S., & Fischer, T. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526114956 · Cited by 142
The CD163-expressing macrophages recognize and internalize TWEAK
Moreno, J. A., Muñoz‐García, B., Martı́n-Ventura, J. L., Madrigal‐Matute, J., Orbe, J., Páramo, J. A., Ortega, L. M., Egido, J., & Blanco‐Colio, L. M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.033 · Cited by 141
Etzerodt, A., Maniecki, M. B., Graversen, J. H., Møller, H. J., Torchilin, V. P., & Moestrup, S. K. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.034 · Cited by 137
Self-citationLevy, A. P., Purushothaman, K., Levy, N. S., Meerarani, P., Strauss, M., Asleh, R., Marsh, S., Cohen, O., Moestrup, S. K., Møller, H. J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.149435 · Cited by 137
Self-citationUrinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis
Mejia-Vilet, J. M., Zhang, X. L., Cruz, C., Cano‐Verduzco, M. L., Shapiro, J. P., Nagaraja, H. N., Morales-Buenrostro, L. E., & Rovin, B. H. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019121285 · Cited by 137
Grønbæk, H., Rødgaard‐Hansen, S., Aagaard, N. K., Arroyo, V., Moestrup, S. K., García, E., Solà, E., Domenicali, M., Piano, S. S., Vilstrup, H., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.021 · Cited by 136
Self-citationUpdates on immunity and inflammation in Parkinson disease pathology
Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 134
Niino, D., Komohara, Y., Murayama, T., Aoki, R., Kimura, Y., Hashikawa, K., Kiyasu, J., Takeuchi, M., Suefuji, N., Sugita, Y., et al. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02514.x · Cited by 133
Baeten, D., Møller, H. J., Delanghe, J., VEYS, E. M., Moestrup, S. K., & Keyser, F. D. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20174 · Cited by 131
Self-citationParenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains
Zhang, Z., Zhang, Z., Schittenhelm, J., Wu, Y., Meyermann, R., & Schluesener, H. J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.006 · Cited by 130
Pey, P., Pearce, R. K., Kalaitzakis, M. E., Griffin, W. S. T., & Gentleman, S. M. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-21 · Cited by 128
Nam, S. J., Go, H., Paik, J. H., Kim, T., Heo, D. S., Kim, C. W., & Jeon, Y. K. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.879713 · Cited by 126
M1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma
Falleni, M., Savi, F., Tosi, D., Agape, E., Cerri, A., Moneghini, L., & Bulfamante, G. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000352 · Cited by 126
Yagi, T., Baba, Y., Okadome, K., Kiyozumi, Y., Hiyoshi, Y., Ishimoto, T., Iwatsuki, M., Miyamoto, Y., Yoshida, N., Watanabe, M., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.01.018 · Cited by 123
Balermpas, P., Rödel, F., Liberz, R., Oppermann, J., Wagenblast, J., Ghanaati, S., Harter, P. N., Mittelbronn, M. G. A., Weiss, C., Rödel, C. M., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.446 · Cited by 122
Kazankov, K., Francisco Barrera, M., Møller, H. J., Rosso, C., Bugianesi, E., David, E., Jouness, R. I. K., Esmaili, S., Eslam, M., McLeod, D. J., et al. (2016) · Liver International · doi:10.1111/liv.13150 · Cited by 122
Komohara, Y., Niino, D., Saito, Y., Ohnishi, K., Horlad, H., Ohshima, K., & Takeya, M. (2013) · Cancer Science · doi:10.1111/cas.12167 · Cited by 121
Antibody–drug conjugates – a perfect synergy
Adair, J. R., Howard, P. W., Hartley, J. A., Williams, D. G., & Chester, K. A. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.693473 · Cited by 120
Baghdadi, M., Endo, H., Takano, A., Ishikawa, K., Kameda, Y., Wada, H., Miyagi, Y., Yokose, T., Ito, H., Nakayama, H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18796-8 · Cited by 119
Maniecki, M. B., Etzerodt, A., Ulhøi, B. P., Steiniche, T., Borre, M., Dyrskjøt, L., Orntoft, T. F., Moestrup, S. K., & Møller, H. J. (2012) · International Journal of Cancer · doi:10.1002/ijc.27506 · Cited by 118
Self-citationSun, W., Wei, F., Li, W.-J., Wei, J.-W., Zhong, H., Wen, Y., Lei, W., Chen, L., Li, H., Lin, H., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.329 · Cited by 118
Expression of Macrophage Antigens by Tumor Cells
Shabo, I., & Svanvik, J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_7 · Cited by 117
From Conventional to Stealth Liposomes: a New Frontier in Cancer Chemotherapy
Cattel, L., Ceruti, M., & Dosio, F. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.supplement-1.94 · Cited by 117
Pillars article: cellular resistance to infection. J. Exp. Med. 1962. 116: 381-406.
Mackaness, G. B. (2014) · PubMed · Cited by 117
Glucocorticoids Shape Macrophage Phenotype for Tissue Repair
Desgeorges, T., Caratti, G., Mounier, R., Tuckermann, J. P., & Chazaud, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01591 · Cited by 117
Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma
Kübler, K., Ayub, T. H., Weber, S. K., Zivanovic, O., Abramian, A., Keyver-Paik, M.-D., Mallmann, M. R., Kaiser, C., Serce, N. B., Kuhn, W. C., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.08.028 · Cited by 113
Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
Møller, H. J., Frikke‐Schmidt, R., Moestrup, S. K., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.154724 · Cited by 112
Self-citationIs macrophage polarization important in rheumatoid arthritis?
Wang, Y., Han, C.-C., Cui, D., Li, Y., Ma, Y., & Wei, W. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.019 · Cited by 111
Marchesi, F., Cirillo, M., Bianchi, A., Gately, M., Olimpieri, O. M., Cerchiara, E., Renzi, D., Micera, A., Balzamino, B. O., Bonini, S., et al. (2014) · Hematological Oncology · doi:10.1002/hon.2142 · Cited by 111
Tentillier, N., Etzerodt, A., Olesen, M. N., Rizalar, F. S., Jacobsen, J., Bender, D., Moestrup, S. K., & Romero-Ramos, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-16.2016 · Cited by 109
Self-citationPark, J. Y., Sung, J., Lee, J.-H., Park, Y.-K., Kim, Y. W., Kim, G. Y., Won, K. Y., & Lim, S. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.09.005 · Cited by 108
Sugaya, M., Miyagaki, T., Ohmatsu, H., Suga, H., Kai, H., Kamata, M., Fujita, H., Asano, Y., Tada, Y., Kadono, T., et al. (2012) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2012.07.007 · Cited by 108
Smiljanovic, B., Radzikowska, A., Kuca‐Warnawin, E., Kurowska, W., Grün, J. R., Stuhlmüller, B., Bonin, M., Schulte‐Wrede, U., Sörensen, T., Kyogoku, C., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211649 · Cited by 108
The Mononuclear Phagocytic System. Generation of Diversity
Gordon, S., & Plüddemann, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01893 · Cited by 108
Tumor-associated macrophages: a short compendium
Prenen, H., & Mazzone, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2997-3 · Cited by 107
CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
Jamiyan, T., Kuroda, H., Yamaguchi, R., Abe, A., & Hayashi, M. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02855-z · Cited by 105
Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients
Clawson, G. A., Matters, G. L., Xin, P., Kawasawa, Y. I., Du, Z., Thiboutot, D. M., Helm, K. F., Neves, R. I., & Abraham, T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134320 · Cited by 104
Wada, N., Zaki, M. A. A., Hori, Y., Hashimoto, K., Tsukaguchi, M., Tatsumi, Y., Ishikawa, J., Tominaga, N., Sakoda, H., Take, H., et al. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04096.x · Cited by 104
Soluble CD163: a biomarker linking macrophages and insulin resistance
Parkner, T., Sørensen, L. P., Nielsen, A. R., Fischer, C. P., Bibby, B. M., Nielsen, S., Pedersen, B. K., & Møller, H. J. (2012) · Diabetologia · doi:10.1007/s00125-012-2533-1 · Cited by 103
Waidmann, O., Brunner, F., Herrmann, E. M., Zeuzem, S., Piiper, A., & Kronenberger, B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.005 · Cited by 103
Shabo, I., Midtbö, K., Andersson, H., Åkerlund, E., Olsson, H., Wegman, P., Gunnarsson, C., & Lindström, A. (2015) · BMC Cancer · doi:10.1186/s12885-015-1935-0 · Cited by 102
Kong, L., Zhu, X., Xu, H., Zhang, J., Lu, L., Wang, W., Zhang, Q., Wu, W., Wang, L., Fan, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059771 · Cited by 99
Lima, L., Oliveira, D. S., Tavares, A., Amaro, T., Cruz, R., Oliveira, M. J., Ferreira, J. A., & Santos, L. L. (2013) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2013.10.012 · Cited by 97
Sandahl, T. D., Grønbæk, H., Møller, H. J., Støy, S. H., Thomsen, K. L., Dige, A. K., Agnholt, J. S., Hamilton-Dutoit, S. J., Thiel, S., & Vilstrup, H. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.262 · Cited by 97
Ni, C., Liu, Y., Xu, Q., Yuan, H., Wang, W. T., Xia, W., Gong, D.-H., Zhang, W., & Yu, K. (2019) · Journal of Cancer · doi:10.7150/jca.33914 · Cited by 97
Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer
Manjunath, Y., Porciani, D., Mitchem, J. B., Suvilesh, K. N., Avella, D. M., Kimchi, E. T., Staveley-O’Carroll, K. F., Burke, D. H., Li, G., & Kaifi, J. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051872 · Cited by 97
Li, Y., Wang, F., Wang, L., Huang, L. J., Wang, J., Zhang, B., & Zhang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3547 · Cited by 95
Roles of cell fusion, hybridization and polyploid cell formation in cancer metastasis
Shabo, I., Svanvik, J., Lindström, A., Lechertier, T., Trabulo, S. M. D., Hulit, J., Sparey, T. J., & Pawelek, J. M. (2020) · World Journal of Clinical Oncology · doi:10.5306/wjco.v11.i3.121 · Cited by 95
Tumor-associated macrophages as a prognostic parameter in multiple myeloma
Suyanı, E., Sucak, G. T., Akyürek, N., Şahin, S., Baysal, N. A., Yağcı, M., & Haznedar, R. (2013) · Annals of Hematology · doi:10.1007/s00277-012-1652-6 · Cited by 93
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma
Liu, S., Zhang, C., Maimela, N. R., Li, Y., Zhang, Z., Yü, P., Huang, L. J., & Zhang, Y. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1601478 · Cited by 92
Advances in Antibody–Drug Conjugate Design: Current Clinical Landscape and Future Innovations
Gauzy, L., Sassoon, I., & Brun, M. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220912955 · Cited by 92
Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma
Zaki, M. A. A., Wada, N., Ikeda, J., Shibayama, H., Hashimoto, K., Yamagami, T., Tatsumi, Y., Tsukaguchi, M., Take, H., Tsudo, M., et al. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1140-8 · Cited by 87
Peripheral Artery Disease Is Associated With a High CD163/TWEAK Plasma Ratio
Moreno, J. A., Dejouvencel, T., Labreuche, J., Smadja, D. M., Dussiot, M., Martín-Ventura, J. L., Egido, J., Gaussem, P., Emmerich, J., Michel, J., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.203364 · Cited by 87
Cao, W., Peters, J. H., Nieman, D. R., Sharma, M., Watson, T. J., & Yu, J.-Z. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.292 · Cited by 86
Alonzi, T., Newton, I. P., Bryce, P. J., Carlo, E. D., Lattanzio, G., Tripodi, M., Musiani, P., & Poli, V. (2004) · Cytokine · doi:10.1016/j.cyto.2003.12.002 · Cited by 85
Yamamoto, K., Makino, T., Sato, E., Noma, T., Urakawa, S., Takeoka, T., Yamashita, K., Saito, T., Tanaka, K., Takahashi, T., et al. (2020) · Cancer Science · doi:10.1111/cas.14328 · Cited by 85
Ramos, R. N., Rodriguez, C., Hubert, M., Ardin, M., Treilleux, I., Ries, C. H., Lavergne, E., Chabaud, S., Colombe, A., Trédan, O., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1108 · Cited by 85
Svendsen, P., Graversen, J. H., Etzerodt, A., Hager, H., Røge, R., Grønbæk, H., Christensen, E. I., Møller, H. J., Vilstrup, H., & Moestrup, S. K. (2017) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2016.11.004 · Cited by 84
Self-citationClinical translation of immunoliposomes for cancer therapy: recent perspectives
Wang, D., Sun, Y., Liu, Y., Meng, F., & Lee, R. J. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517747 · Cited by 84
Wang, H., Hu, W., Xia, Z., Liang, Y., Lu, Y., Lin, S.-X., & Tang, H. (2019) · Journal of Cancer · doi:10.7150/jca.30102 · Cited by 84
Maras, J. S., Maiwall, R., Gowda, H., Das, S., Hussain, M. S., Kumar, C., Bihari, C., Rastogi, A., Kumar, M., Trehanpati, N., et al. (2014) · Hepatology · doi:10.1002/hep.27636 · Cited by 83
Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI
Tarín, C., Carril, M., Martín-Ventura, J. L., Markuerkiaga, I., Padró, D., Llamas‐Granda, P., Moreno, J. A., García, I., Genicio, N., Plaza‐García, S., et al. (2015) · Scientific Reports · doi:10.1038/srep17135 · Cited by 82
Sakakura, K., Takahashi, H., Kaira, K., Toyoda, M., Murata, T., Ohnishi, H., Oyama, T., & Chikamatsu, K. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.70 · Cited by 79
Shamaei, M., Mortaz, E., Pourabdollah, M., Garssen, J., Tabarsi, P., Velayati, A. A., & Adcock, I. M. (2017) · Human Immunology · doi:10.1016/j.humimm.2017.10.009 · Cited by 79
Zhang, T., Li, H., Vanarsa, K., Gidley, G., Mok, C. C., Petri, M., Saxena, R., & Mohan, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00671 · Cited by 79
Fujita, Y., Okamoto, M., Goda, H., Tano, T., Nakashiro, K., Sugita, A., Fujita, T., Koido, S., Homma, S., Kawakami, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110378 · Cited by 78
Intergroup, O. B. O. T. I. M., Massi, D., Rulli, E., Cossa, M., Valeri, B., Rodolfo, M., Merelli, B., Logu, F. D., Nassini, R., Vecchio, M. D., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0797-4 · Cited by 77
Waidmann, O., Köberle, V., Bettinger, D., Trojan, J., Zeuzem, S., Schultheiß, M., Kronenberger, B., & Piiper, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.008 · Cited by 74
Wang, J., Gao, K., Lei, W., Dong, L., Xuan, Q., Feng, M., Wang, J., Ye, X., Jin, T., Zhang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14289 · Cited by 74
Clawson, G. A., Matters, G. L., Xin, P., McGovern, C. O., Wafula, E. K., dePamphilis, C. W., Meckley, M., Wong, J. Y., Stewart, L., D’Jamoos, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184451 · Cited by 74
Mendonça, V. R. R., Luz, N. F., Santos, N. J. G., Borges, V. M., Gonçalves, M. S., Andrade, B. B., & Barral-Netto, M. (2012) · Infection and Immunity · doi:10.1128/iai.05933-11 · Cited by 72
Minami, K., Hiwatashi, K., Ueno, S., Sakoda, M., Iino, S., Okumura, H., Hashiguchi, M., Kawasaki, Y., Kurahara, H., Mataki, Y., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5959 · Cited by 72
Wang, S., Sun, M., Gu, C., Wang, X., Chen, D., Zhao, E., Jiao, X., & Zheng, J. (2014) · European Journal Of Oral Sciences · doi:10.1111/eos.12131 · Cited by 71
Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs
Needham, L. A., Davidson, A. H., Bawden, L. J., Belfield, A. J., Bone, E. A., Brotherton, D. H., Bryant, S., Charlton, M. H., Clark, V. L., Davies, S. J., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183640 · Cited by 71
Li, Y., Zhi-hu, S., Wang, X., Gu, K., & Zhai, Z. (2019) · BMC Cancer · doi:10.1186/s12885-019-6208-x · Cited by 71
Cited by
Metabolism of tissue macrophages in homeostasis and pathology
Wculek, S. K., Dunphy, G., Heras-Murillo, I., Mastrangelo, A., & Sancho, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00791-9 · Cited by 501
Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Gusev, E., & Sarapultsev, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097910 · Cited by 312
Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
Zhang, Q., & Sioud, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087493 · Cited by 300
Kohlhepp, M. S., Liu, H., Tacke, F., & Guillot, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1129831 · Cited by 27
Liu, Z., Li, G., Li, X., Wang, Y., Liao, L., Yang, T., Han, C., Huang, K., Chen, C., Li, X., et al. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106093 · Cited by 7
Metadata
- Authors
- Skytthe, M. K., Graversen, J. H., & Moestrup, S. K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-07-31
- Volume
- 21
- Issue
- 15
- Pages
- 5497
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3046770314
- Cited by
- 261
- References
- 308
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.